Does postoperative corticosteroid management prevent atrial fibrillation after mitral valve surgery?
Phase 1
- Conditions
- new onset atrial fibrallation and paroxysmal atrial fibrillationTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Registration Number
- EUCTR2018-001431-40-FI
- Lead Sponsor
- Kuopio University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
mitral valve surgery (plasty or prostesis), adult, willing to participate, not in chronic atrial fibrillation preoperatively
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 120
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 120
Exclusion Criteria
not willing to participate, insulin dependent diabetes, active ulcus, oversensitivity or allergy to hydrocortison, chronic atrial fibrillation, psychosis, prolonged stay in intensive care unit postoperatively
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method